Prot #1042-SE-3003: A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus

Project: Research project

Project Details

StatusActive
Effective start/end date4/8/22 → 4/8/25

Funding

  • Peachtree BioResearch Solutions, Inc. (Prot #1042-SE-3003 - Amendment 4 // Prot #1042-SE-3003 - Amen...)
  • Marinus Pharmaceuticals, Inc. (Prot #1042-SE-3003 - Amendment 4 // Prot #1042-SE-3003 - Amen...)